ArticleCardiovascular diagnosis and therapy2026
Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction.
Jingjiang Pi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.